Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Oral SARS-CoV-2 host responses predict the early COVID-19 disease course

William T Seaman, Olive Keener, Wenwen Mei, Katie R Mollan, Corbin D Jones, Audrey Pettifor, Natalie M Bowman, UNC OBSc Working Group, Frank Wang, Jennifer Webster-Cyriaque
doi: https://doi.org/10.1101/2023.03.06.23286853
William T Seaman
1Division of Oral and Craniofacial Health Sciences, University of North Carolina, Chapel Hill, NC
9National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD
10School of Medicine, University of North Carolina, Chapel Hill, NC
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olive Keener
2North Carolina School of Math and Science, Durham, NC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wenwen Mei
8Department of Biostatistics, University of North Carolina, Chapel Hill, NC
10School of Medicine, University of North Carolina, Chapel Hill, NC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katie R Mollan
8Department of Biostatistics, University of North Carolina, Chapel Hill, NC
10School of Medicine, University of North Carolina, Chapel Hill, NC
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Corbin D Jones
3Department of Biology, University of North Carolina, Chapel Hill, NC
10School of Medicine, University of North Carolina, Chapel Hill, NC
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Audrey Pettifor
4Department of Epidemiology, University of North Carolina, Chapel Hill, NC,
10School of Medicine, University of North Carolina, Chapel Hill, NC
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalie M Bowman
5Division of Infectious Diseases, University of North Carolina, Chapel Hill, NC
10School of Medicine, University of North Carolina, Chapel Hill, NC
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
5Division of Infectious Diseases, University of North Carolina, Chapel Hill, NC
10School of Medicine, University of North Carolina, Chapel Hill, NC
Frank Wang
6Biomedomics Inc, Morrisville, NC
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Webster-Cyriaque
1Division of Oral and Craniofacial Health Sciences, University of North Carolina, Chapel Hill, NC
7Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC
9National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD
10School of Medicine, University of North Carolina, Chapel Hill, NC
DDS, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Jennifer.Webster-cyriaque@nih.gov
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives Oral fluids provide ready detection of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and host responses. This study sought to determine relationships between oral virus, oral anti-SARS-CoV-2-specific antibodies, and symptoms.

Methods Saliva/throat wash (saliva/TW) were collected from asymptomatic and symptomatic, nasopharyngeal (NP) SARS-CoV-2 RT-qPCR+, subjects (n=47). SARS-CoV-2 RT-qPCR, N-antigen detection by immunoblot and lateral flow assay (LFA) were performed. RT-qPCR targeting viral subgenomic RNA (sgRNA) was sequence confirmed. SARS-CoV-2-anti-S protein RBD LFA assessed IgM and IgG responses. Structural analysis identified host salivary molecules analogous to SARS-CoV-2-N-antigen. Statistical analyses were performed.

Results At baseline, LFA-detected N-antigen was immunoblot-confirmed in 82% of TW. However, only 3/17 were saliva/TW qPCR+. Sixty percent of saliva and 83% of TW demonstrated persistent N-antigen at 4 weeks. N-antigen LFA signal in three negative subjects suggested potential cross-detection of 4 structurally analogous salivary RNA binding proteins (alignment 19-29aa, RMSD 1-1.5 Angstroms). At entry, symptomatic subjects demonstrated replication-associated sgRNA junctions, were IgG+ (94%/100% in saliva/TW), and IgM+ (75%/63%). At 4 weeks, SARS-CoV-2 IgG (100%/83%) and IgM (80%/67%) persisted. Oral IgG correlated 100% with NP+PCR status. Cough and fatigue severity (p=0.0008 and 0.016), and presence of nausea, weakness, and composite upper respiratory symptoms (p=0.005, 0.037 and 0.017) were negatively associated with oral IgM. Female oral IgM levels were higher than male (p=0.056).

Conclusion Important to transmission and disease course, oral viral replication and persistence showed clear relationships with select symptoms, early Ig responses, and gender during early infection. N-antigen cross-reactivity may reflect mimicry of structurally analogous host proteins.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

UNC IRB study 200792 UNC IRB study 201771 UNC IRB study 071431

Funding Statement

The work here was supported by NCI U54CA260543-01 This work was supported by the North Carolina Policy Collaboratory through appropriation from the North Carolina General Assembly (NCGA) in support of research on treatment, community testing, and prevention of COVID-19 (as mandated by the NCGA in subdivision (23) of Section 3.3 of Session Law 2020-4).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

University of North Carolina at Chapel Hill Office of Human Research Ethics, Institutional Review Board Aprroval granted

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted March 08, 2023.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Oral SARS-CoV-2 host responses predict the early COVID-19 disease course
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Oral SARS-CoV-2 host responses predict the early COVID-19 disease course
William T Seaman, Olive Keener, Wenwen Mei, Katie R Mollan, Corbin D Jones, Audrey Pettifor, Natalie M Bowman, UNC OBSc Working Group, Frank Wang, Jennifer Webster-Cyriaque
medRxiv 2023.03.06.23286853; doi: https://doi.org/10.1101/2023.03.06.23286853
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Oral SARS-CoV-2 host responses predict the early COVID-19 disease course
William T Seaman, Olive Keener, Wenwen Mei, Katie R Mollan, Corbin D Jones, Audrey Pettifor, Natalie M Bowman, UNC OBSc Working Group, Frank Wang, Jennifer Webster-Cyriaque
medRxiv 2023.03.06.23286853; doi: https://doi.org/10.1101/2023.03.06.23286853

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (135)
  • Cardiovascular Medicine (1748)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (653)
  • Epidemiology (10784)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2935)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1919)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12499)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (321)
  • Neurology (2782)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (555)
  • Occupational and Environmental Health (597)
  • Oncology (1457)
  • Ophthalmology (441)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (334)
  • Psychiatry and Clinical Psychology (2633)
  • Public and Global Health (5340)
  • Radiology and Imaging (1004)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (724)
  • Rheumatology (329)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)